Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 919-925

  Hauge, Majbritt ^a   Jespersgaard, Christina ^a   Poulsen, Knud ^a   Kilian, Mogens ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; DNA FRAGMENT; HYALURONIDASE; IMMUNOGLOBULIN A; PEPTIDASE; RIBOSOME RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; ENZYME ACTIVITY; EVOLUTION; GENE LINKAGE DISEQUILIBRIUM; HUMAN; IMMUNITY; INFANT; NEWBORN SEPSIS; NONHUMAN; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPING; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0030043393     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.919-925.1996     Document Type: Article

References (25)

1. Baker, C. J., and F. F. Barrett. 1974. Group B streptococcal infection in infants: the importance of the various serotypes J Am. Med. Assoc. 230: 1158-1160.
2. Bevanger, L. 1983. Ibc proteins as serotype markers of group B streptococci. Acta Path. Microbiol. Immunol Scand Sect. B 91:231-234.
3. Bohnsack, J. F., K. W. Mollison, A. M. Buko, J. C. Ashworth, and H. R Hill. 1991. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. Biochem. J. 273:635-640.
4. Caugant, D. A., L. O. Frøholm, K. Bøevre, E. Holten, C. E. Frasch, L. F. Mocca, W. D. Zollinger, and R. K. Selander. 1986. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad. Sci. USA 83:4927-4931
5. Cleary, P. P., J. Handley, A. N. Suvorov, A. Podbielski, and P. Ferrieri. 1992. Similarity between the group B and A streptococcal C5a peptidase genes. Infect. Immun. 60:4239-4244.
6. Dillon, H. C., Jr., S. Khare, and B. M. Gray. 1987. Group B streptococcal carriage and disease: a 6-year prospective study. J. Pediatr. 110:31-36.
7. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults N Engl. J. Med 328: 1807-1811.
8. Helmig, R., N. Uldbjerg, J. Boris, and M. Kilian. 1993. Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women J. Infect Dis. 168:904-909.
9. Hohwy, J., and M. Kilian. 1995. Clonal diversity of the Streptococcus mitis biovar 1 population in the human oral cavity and pharynx. Oral Microbiol. Immunol. 10:19-25
10. Jerlstrom, P. G., G. S. Chhatwal, and K. N. Timmis. 1991 The IgA-binding β antigen of the c protein complex of group B streptococci: sequence determination of its gene and detection of two binding regions. Mol. Microbiol. 5:843-849.
11. Lancefield, R. C., M. McCarty, and W. N. Everly. 1975. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens J Exp Med. 142: 165-179.
12. Lin, B., S. K. Hollingshead, J. E. Coligan, M. L. Egan, J. R. Baker, and D. G. Pritchard. 1994. Cloning and expression of the gene for group B streptococcal hyaluronate lyase. J. Biol. Chem. 269:30113-30116.
13. Madoff, L. C., J. L. Michel, and D. L. Kasper. 1991 A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect. Immun. 59:204-210.
14. Maynard Smith, J. 1995. Do bacteria have population genetics?, p. 1-12. In S. Baumberg, J. P. W. Young, E. M H. Wellington, and J. R Saunders (ed.), Population genetics of bacteria. Cambridge University Press, Cambridge.
15. Michel, J. L., L. C. Madoff, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1991 Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect. Immun. 59:2023-2028.
16. Michel, J. L., L. C. Madoff, K. Olson, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1992 Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc. Natl Acad. Sci. USA 89:10060-10064
17. Milligan, T. W., C. J. Baker, D. C. Straus, and S. J. Mattingly. 1978. Association of elevated levels of extracellular ueuraminidase with clinical isolates of type III group B streptococci. Infect. Immun 21:738-746
18. Musser, J. M., J. S. Kroll, E. E. Moxon, and R. K. Selander. 1988. Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc. Natl. Acad Sci. USA 85:7758-7762.
19. Musser, J. M., S. J. Mattingly, R. Quentin, A. Goudeau, and R. K. Selander. 1989. Identification of a high-virulence clone of Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease Proc. Natl. Acad. Sci. USA 86:4731-4735.
20. Musser, J. M., P. M. Schlievert, A. W. Chow, P. Evans, B. N. Kreiswirth, V. T. Rosdahl, A. S. Naidu, W. Witte, and R. K. Selander. 1990. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl. Acad. Sci. USA 87:225-229.
21. Pritchard, D. G., and B. Lin. 1993. Group B streptococcal neuraminidase is actually a hyaluronidase. Infect. Immun. 61:3234-3239
22. Rubens, C. E., M. R. Wessels, L. M. Heggen, and D. L. Kasper. 1987 Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl. Acad. Sci. USA 84:7208-7212.
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
24. Smith, R. F., and N. P. Willett. 1968. Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. Appl. Microbiol. 16:1434-1436.
25. Stålhammar-Carlemalm, M., Stenberg, L. and G. Lindahl. 1993. Protein Rib: A novel group B streptococcal surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp. Med 177:1593-1603.